Capex Down, Cash Up, Backlog at $230 Billion: Upgrading Lockheed Martin to Outperform

Results vs. Consensus

The Q2 2025 comparative is unusable as an operating benchmark, for the same reason we flagged at the Q4 print: it absorbed $1,615M of reach-forward losses across the classified Aeronautics program, the Canadian Maritime Helicopter Program and the Turkish Utility Helicopter Program, driving segment margin to 3.1%. Every year-over-year profit growth rate below is a comparison artifact. We read the sequential table, the six-month table, and management's ex-adjustment figure of 7% underlying sales growth instead.

Year-over-Year Comparison

Sequential Comparison

This is the table that carries the argument. Q1 2026 was a genuinely weak quarter with roughly $230M of unfavourable adjustments and negative cash. Q2 recovered on every line.

Six Months 2026

Quarterly figures tie to the half exactly: sales of $18,021M plus $20,063M equals $38,084M, and segment operating profit of $1,823M plus $2,162M equals $3,985M.

Assessment: revenue. Seven percent underlying growth is the fastest company-wide rate management has quantified in our coverage of this name, and the acceleration is exactly where the thesis said it should come from. Missiles and Fire Control added $668M of sales, more than a third of the company's total increase, from a segment that is 20% of revenue. Management has now guided second-half growth to 7% to 12% with every segment faster than the first half, and the implied second-half growth rate embedded in the raised guide is 9.6%, comfortably inside that band. The one caveat worth holding is that this is ramp revenue, and ramp revenue is recognised at conservative early-stage profit rates, which is why the guidance raise looks the way it does below.

Assessment: margins. The reported 763bps of year-over-year margin expansion is meaningless. The meaningful numbers are the 66bps sequential improvement and the 11.35% the quarter would have posted without the RMS adjustments. Set against the 10.82% margin the second half requires to meet the raised guide, Q2 came within four basis points on a reported basis and cleared it comfortably excluding the RMS items. MFC's 53bps of expansion is the single most encouraging datapoint: management committed in January to dilution of no more than 20 to 30 basis points through the ramp and has instead delivered expansion two quarters running. That is a commitment kept with room to spare, which is worth noting given the capital-intensity commitment this same team broke in January.

Assessment: EPS. For the first time in our coverage, the earnings algorithm is working from the top down rather than from the share count up. Segment profit rose $339M sequentially and EPS rose $1.50, with below-the-line items contributing rather than subtracting. The share count is doing almost nothing: down 1.4% year over year on residual effect from repurchases that have now stopped entirely. That is a healthier composition than any of the three prior quarters, and it is the answer to the bear point we opened at initiation. It also means that if management restores the buyback, the EPS trajectory improves from an already-clean base rather than depending on it.

Segment Performance

Backlog by Segment

Last quarter backlog fell $7,195M and we downgraded that thesis pillar to at risk. It has been answered emphatically, and the composition tells you where the company's future is.

Assessment. Missiles and Fire Control backlog nearly doubled in a single quarter, from $46,565M to $87,882M, and now exceeds Aeronautics by $33.5B. At the end of 2024 Aeronautics carried the largest book in the company by a wide margin. The $35B THAAD multi-year is the largest single contract in our coverage of this name and it converts a framework agreement into a definitized seven-year commitment, which was the specific milestone we said we were waiting for. Consolidated backlog of 2.85x guided sales on a 3.2:1 quarterly book-to-bill is well above the 2.48x it carried entering 2025 and the deepest coverage in our coverage period. Aeronautics continuing to draw down, $5,079M year to date, remains the counterweight and reflects a segment delivering against contracts booked in prior years.

Missiles and Fire Control — the thesis, contracted

MFC grew sales 19.5% to $4,101M on roughly $560M of integrated air and missile defense volume (PAC-3 and THAAD) and roughly $100M of PrSM, with operating profit up 24.0% to $594M including roughly $60M of net favourable adjustments. Margin expanded 53bps to 14.48%.

The quarter's defining event was the Missile Defense Agency's $35B seven-year award to quadruple THAAD production, plus a roughly $3B Army PrSM contract covering the current version and a successor with twice the range from the same launcher, and a HIMARS award valued up to $1.1B across the U.S. Army, Marine Corps and up to five allied nations.

On the forward margin path, management held its January framing while raising the destination.

"I think what you're seeing this year is what we should generally expect to see in the future, which is MFC margins in kind of the high 13s, low 14s, which is what we've managed to do when we're really hitting our ramps and hitting our marks, which we've been doing here pretty consistently on the MFC side."
— Evan Scott, Chief Financial Officer

Assessment: This segment has now delivered growth and margin discipline for three consecutive quarters while absorbing the front end of the largest capacity expansion in its history. The dilution has been 8bps and then negative 53bps against a 30bps ceiling. With $87,882M of backlog and a definitized seven-year THAAD contract, the demand side of this pillar is no longer a forecast. What remains unproven is the physical ramp, which management has consistently said takes three to four years, and the PAC-3 multi-year still needs to definitize in the second half.

Aeronautics — recovered, with a delivery question

Aeronautics grew sales 9.3% to $8,112M, of which roughly $475M was F-35 production volume and roughly $360M the absence of the prior-year reach-forward loss impact, partly offset by $120M of lower F-16 and C-130 sustainment. Operating profit swung $858M to $760M at a 9.4% margin, though roughly $160M of lower net favourable adjustments partly offset the comparison benefit. F-16 deliveries resumed with two aircraft and C-130J deliveries reached seven, against one a year ago.

Management framed the F-16 recovery as the template for how the portfolio should be judged.

"So we did a redesign, got the redesign complete, redid flight test and began deliveries again on F-16. That's the resilience you should look for."
— James Taiclet, Chairman, President and Chief Executive Officer

The segment's 2026 guide rose to $31.7B to $32.7B of sales with $3.00B to $3.08B of profit, though management flagged the margin as modestly lower than prior guidance.

"Margins are pegged modestly lower than our prior guidance as we scale up new contracts in F-35 production expand sustainment work and absorb the F-16 and C-130 challenges we realized in Q1."
— Mark Kvasnak, Vice President, Investor Relations

Assessment: The F-16 problem was diagnosed, fixed and shipped within one quarter, which is genuinely the resilience management claims and is a better outcome than we assumed in April. The open issue is deliveries: 19 F-35s in the quarter and 51 in the half, against 50 and 97 a year ago, leaves 105 required in the second half to hold the 156-aircraft annual rate. A fourteen-week fourth quarter helps, but this is a large back-end load that the release does not explain and no analyst pressed on.

Rotary and Mission Systems — the one segment still misbehaving

RMS grew sales 9.0% to $4,354M, with roughly $255M from the absence of the prior-year Sikorsky reach-forward loss impact and roughly $115M of genuine volume from MIC2, undersea and River Class programs. Operating profit swung $609M to $437M at a 10.0% margin, but the composition included roughly $65M of unfavourable Heavy Lift adjustments and roughly $50M on Seahawk. A $2.3B radar contract drove the segment's guidance raise to $17.7B to $18.1B of sales.

Assessment: Five consecutive quarters of Sikorsky problems: helicopter reach-forward losses in Q2 2025, a $500M in-year revenue cut in Q3, unfavourable Black Hawk adjustments in Q4, CH-53K and Seahawk adjustments in Q1, and Heavy Lift and Seahawk adjustments now. The programs rotate; the pattern does not. Against that, the radar business is genuinely accelerating and the segment's underlying volume growth was real this quarter rather than a comparison. RMS is the reason we do not close the fixed-price bear point.

Space — good business, bad launch partner

Space grew sales 5.7% to $3,496M on roughly $190M of strategic and missile defense volume (Fleet Ballistic Missile and Next Generation Interceptor), with operating profit up 2.5% to $371M and margin down 34bps to 10.6%. The segment was selected as an awardee to develop space-based interceptor prototypes under Golden Dome with a capability demonstration expected by 2028, and booked $1.4B of cumulative Conventional Prompt Strike modifications.

It was also the only segment whose profit guidance moved lower.

"The space full year profit outlook was lowered to between $1.34 billion and $1.38 billion due to reduced ULA equity earnings because of the ongoing technical investigation of the Vulcan launch anomaly experienced earlier this year."
— Mark Kvasnak, Vice President, Investor Relations

Assessment: The operating business is performing and the Golden Dome space-based interceptor award is the first time that opportunity has produced a contract rather than a description. The drag is entirely from the United Launch Alliance joint venture, whose equity earnings have now been a negative swing factor in three of the four quarters we have covered. A 50% stake in a launch provider under technical investigation is an odd asset for a company otherwise sharpening its portfolio, and it is worth asking whether it still earns its place.

Key Topics & Management Commentary

Overall Management Tone: The most confident of the four calls in our coverage, and for the first time the confidence is grounded in delivered results rather than in contracted demand. Management addressed the stock's weakness directly when asked rather than deflecting, disclosed the total munitions capital commitment it had withheld for two quarters, and explained the contract economics in more technical depth than at any prior point. The one place it remained evasive was capital returns, where the buyback went unmentioned in the prepared remarks and unaddressed in Q&A.

1. The capex cut, and why it is the most important line in the release

Every other guidance line moved the direction you would expect after a strong quarter. Capital expenditure moved the other way, guided down $450M to $2,000M to $2,400M, which took capex from 3.37% to 2.72% of guided sales. Free cash flow rose by precisely the same $450M.

"We are also updating our capital expenditure guidance to a range of $2 billion to $2.4 billion reflecting efficiencies realized in MFC's munitions buildout. Expanding Munitions capacity as quickly as possible is our top priority, and our teams are relentlessly pursuing the most efficient ways to do so. Our framework agreements and related awards remain cash neutral so these efficiencies are well aligned with our customers' objectives."
— Evan Scott, Chief Financial Officer

Management attributed part of the reduction to timing, specifically a facility it decided to lease for a year rather than buy for tax reasons, and part to genuine efficiency from the partnership with the Department of War on the scale-up. Critically, it sized the total commitment for the first time.

"but our commitment to invest a total of between $8 billion to $9 billion of capital in munition scaling is unchanged."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: In January we opened a bear point on capital intensity because management had reversed a commitment not to raise investment as a percentage of revenue, and refused to size the program. Both halves of that objection were answered this quarter: the program is $8B to $9B, and the 2026 tranche is coming in $450M below plan while the capacity target is unchanged. A company delivering more capacity for less capital, with the customer funding the working capital, is the opposite of the story we were worried about. This single disclosure does more for the investment case than the earnings beat.

2. The repricing mechanism: why these contracts are structurally different

The most economically consequential explanation of the call had nothing to do with the quarter. Under traditional federal acquisition regulation cost accounting, even a fixed-price contract gets repriced downward when the contractor's costs fall, which means efficiency investments are recovered by the customer rather than the investor. The framework agreements remove that.

"What the framework agreements do is take that away. In other words, as Evan suggested, if we get efficiencies while we ramp up our product line, we get to keep in our own profitability."
— James Taiclet, Chairman, President and Chief Executive Officer

Management described a threshold above which gains are shared ratably with the government rather than fully returned, framing it as fair to both sides while preserving the industrial incentive to invest.

Assessment: This is the answer to a question the defense sector has struggled with for forty years, and it explains why Lockheed is willing to commit $8B to $9B of capital to a demand signal that historically could evaporate. If a contractor keeps its productivity gains, robotics and automation investment has a return; if the customer claws it back at the next cost review, it does not. Combined with the inflation escalator and the clawback provisions disclosed in April, the munitions franchise now has an economic structure that supports margin expansion rather than merely volume growth. This is the strongest argument for a higher multiple in the whole story.

3. Cash conversion, restored exactly as promised

Free cash flow of $2,917M reversed Q1's $291M deficit and carried the first half to $2,626M, and management explicitly tied the recovery back to the commitment made in April.

"We restored the temporary dip in free cash flow that resulted from the ERP rollout last quarter, reflecting the effectiveness of the planned recovery we outlined earlier this year."
— Evan Scott, Chief Financial Officer

Six-month free cash flow of $2,626M is 3.3x the $805M generated in the same period of 2025, and the raised full-year guide of $7,000M to $7,200M requires $4,474M in the second half against $6,103M actually delivered in the second half of 2025.

Assessment: Management made a specific, falsifiable prediction in April and it came true within one quarter. That is worth more to the credibility ledger than the size of the number. The second-half requirement is now materially easier than last year's actual performance, which converts the free cash flow guide from the most doubtful line in the model to among the most comfortable. This was the primary condition we set for an upgrade, and it was met without ambiguity.

4. Decomposing the guidance raise: revenue at 2.5% incremental margin

The raise deserves reading carefully. Sales went up $2,000M at the midpoint and segment operating profit went up $50M, an incremental margin of 2.5%. Guided segment margin consequently fell from 10.86% to 10.65%.

Assessment: The 2.5% incremental margin is not a warning sign, it is percentage-of-completion accounting behaving as management described in January: ramp revenue books at conservative early-stage profit rates and steps up as risk retires. It does mean the revenue raise carries almost no 2026 profit, and that anyone modelling the munitions ramp should push the profit recognition into 2028 and beyond rather than capitalising it now. It also means the free cash flow raise is a capex story, not an earnings story, since cash from operations guidance is unchanged. Both facts are worth stating plainly because the headline framing obscures them.

5. Backlog at $230B and the definitization milestone

The $35B seven-year THAAD contract is the largest award in our coverage and it matters more for what it represents than for its size: the second munitions framework to convert into a definitized contract, following PAC-3's $4.8B undefinitized award in April. Management expects the PAC-3 multi-year to definitize in the second half.

Book-to-bill was 3.2:1 on $65B of orders, taking backlog to 2.85x guided sales.

Assessment: In April we wrote that MFC's future growth depended on definitizing the multiyear agreements rather than on the book it already held. One quarter later the segment's backlog has nearly doubled on exactly that mechanism. The remaining conversion risk is PAC-3, which management expects in the second half. Backlog is now covering nearly three years of sales, and the composition has shifted decisively from long-cycle aircraft to munitions with contracted rate escalation.

6. Investing ahead of orders, and the mindset behind it

Management described a deliberate shift toward funding development and capacity before contracts exist, driven by mission technology roadmaps built with customers rather than by responding to requests for proposal. The illustration offered was target-weapon matching: PAC-3 MSE is more capable than many threats require, so the company self-funded a lower-cost interceptor for short-range ballistic missiles, cruise missiles and drones.

"So yes, we are investing in the manufacturing and design capabilities before the orders come in. And I think that's the right way to run the company, Scott."
— James Taiclet, Chairman, President and Chief Executive Officer

The counter-UAS system taken from concept to live-fire test in under 45 days was assembled from existing components: a combat-proven battle manager, a radar from a Lockheed Martin Ventures portfolio company, a containerised launcher, and JAGM missiles already produced at scale.

Assessment: The 45-day integration is impressive and the economics are sound because nothing in it was invented; the value was in the systems integration, which is what this company is actually good at. Management framed these self-funded programs as incremental to the guided forecast rather than embedded in it, which is the correct disclosure and means any orders are upside. We assign no value to them and note that the spending is real while the revenue is not yet.

7. Whether commercial-style contracting survives a change of administration

The sharpest strategic question of the call raised the C-130J precedent, where Lockheed self-funded development, earned commercial-like margins, and then had the commercial designation reversed by the Pentagon. Management's answer was that the difference this time is enforceability.

"We need the confidence to act as we would act in a commercial environment to make investments to solve these national defense problems."
— James Taiclet, Chairman, President and Chief Executive Officer

He went further, saying the company will not repeat the C-130J exposure.

"And we don't plan to ever put ourselves in a risk position where we don't have that confidence in the contract that we didn't have for the C-130, We're not doing that anymore."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: The honest answer is that this risk cannot be eliminated, only contracted around, and management is clear-eyed about that. Seven-year enforceable agreements with clawback and escalator provisions are materially harder to unwind than an administrative designation. But the C-130J precedent is a real one and the agreements have not been tested across a change of government. We treat the political durability of the commercial contracting model as the principal long-term risk to the munitions thesis, ahead of execution.

8. Both classified programs stable on new baselines

Asked to update on the two classified programs that produced the largest charges of the cycle, management confirmed the MFC program has been unchanged since Q4 2024 and the Aeronautics program since Q2 2025.

"In both cases, we set new baselines and we have established that we can continue to hit those. They're both aggressive, we've got a lot of technical work to do, but we're making great progress and have shown stability in our ability to execute."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: Four consecutive quarters without a charge on the Aeronautics program and six on the MFC program is the evidentiary threshold we said we needed at initiation. The bear point on fixed-price development risk is now genuinely contained at the classified programs. It is not contained at Sikorsky, which is a different and, for now, smaller problem.

9. The stock, addressed directly

An analyst put the disconnect plainly: record backlog and accelerating revenue against a share price that had fallen 24% from its high. Management's answer located the gap in investor understanding of the new contracting model rather than in the fundamentals.

"So as we continue to have the contracts add to the backlog and be able to get better line of sight to the near-term multiyear revenue growth profile I think we'll see that more translate."
— Evan Scott, Chief Financial Officer

Assessment: Management is largely right, and this quarter is the evidence. The market has been unwilling to pay for framework agreements and has been willing to pay for definitized contracts, which is a rational distinction rather than a misunderstanding. The 10.5% move on the day the THAAD contract landed in backlog makes the point better than the commentary does. The remaining discount closes as PAC-3 definitizes and as the ramp converts to reported revenue.

10. International capacity and co-production

Management signed a memorandum of understanding with Rheinmetall toward a European center of excellence, and the United States, Germany, the Netherlands, Poland and Sweden committed to explore a dedicated PAC-3 facility in Europe. The stated logic is that moving an older production line into allied factory space frees domestic floor space for the newer automated PrSM line without constructing another building, with the partner providing the space, workforce and investment.

Assessment: This is a capital-efficiency mechanism disguised as a diplomatic initiative, and it is part of why capex came down. Allied co-production converts capacity expansion from a balance-sheet item into a partnership, places sustainment where allied forces operate, and hardens the political durability of the programs by giving partner governments industrial stakes. It also introduces execution and intellectual property complexity that has historically gone badly in this industry, which is worth watching rather than assuming.

11. Ultra Maritime and the return of inorganic growth

After quarter end, Lockheed signed an agreement to acquire Ultra Maritime, adding undersea sensing and autonomous sea drone capabilities. This follows the January call in which management said it would keep its powder dry for acquisition opportunities, having had a prior deal blocked.

Assessment: A capability acquisition in a growing domain, funded from a balance sheet that just generated $2.9B of quarterly free cash flow, is a reasonable use of capital. But it lands in a period where no shares are being repurchased, and it is the second competing use of cash to appear since the buyback stopped. We would rather see the repurchase framework restored alongside disciplined acquisitions than see acquisitions substitute for it.

Guidance & Outlook

Segment guidance moved higher on sales in all four cases and higher on profit in three. Aeronautics guides to $31.7B to $32.7B of sales and $3.00B to $3.08B of profit; Missiles and Fire Control to $16.5B to $16.9B and $2.30B to $2.35B; Rotary and Mission Systems to $17.7B to $18.1B and $1.86B to $1.89B; Space to $13.85B to $14.05B with profit lowered to $1.34B to $1.38B on the ULA equity earnings drag. The segment midpoints sum to $80.75B of sales and $8.60B of profit, ties to the consolidated midpoints.

What the raise requires in the second half: $42,666M of sales, which is 9.6% growth over the second half of 2025 and sits inside the 7% to 12% management guided; $4,615M of segment operating profit at a 10.82% margin, against the 10.78% just delivered and the 11.35% delivered excluding the RMS adjustments; $15.92 of EPS; and $4,474M of free cash flow, which is $1,629M less than the second half of 2025 actually produced. Capital expenditure of $1,371M remains in the second half against $829M spent in the first.

The clean-basis check. We have applied the same normalisation each quarter, and it still matters. Against a clean 2025 base of $8,358M of segment operating profit and $28.51 of EPS, the raised 2026 guide represents 2.9% profit growth and 6.3% EPS growth, with guided margin 49bps below clean 2025. The reported 28% profit growth remains a charge-recovery artifact. What changed this quarter is that the cash story no longer needs the same caveat: free cash flow of $7,100M against $6,908M is a clean comparison, and the second-half requirement is genuinely undemanding.

Street at: Consensus entering the print was $7.22 on the quarter and had been anchored near the April guide midpoints of $29.80 and $78,750M. The raise moves the Street up roughly 2% on 2026 EPS and roughly 2.5% on sales.

Guidance style: Unchanged and now well established across four quarters of observation. Lockheed beat every 2025 guided line, held 2026 unchanged through a weak Q1 rather than trimming to a lower Street, and raised on strength rather than incrementally. The one break in the pattern is capex, where the company guided down while holding the capacity target, which is the first time in our coverage it has delivered more for less.

Analyst Q&A Highlights

Whether capital is being deployed ahead of formal awards

The opening question asked about the manufacturing scale-up timeline for the newer self-funded products and whether the company would commit capital ahead of contracts. The answer was an unambiguous yes, framed within a five-year shift toward building mission technology roadmaps with customers rather than waiting for requests for proposal, illustrated with the target-weapon-matching logic behind a lower-cost interceptor developed without a solicitation.

Q: "But I was wondering if you could just speak to what type of time line the business is working to in terms of the manufacturing scale up? For those solutions? And also if you're willing to deploy CapEx for those scale-ups ahead of formal awards?"
— Scott Deuschle, Deutsche Bank

A: "So we are building those technology road maps and investing based on our confidence in the ability to make good choices on deciding -- or predicting what the armed forces are going to need."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: A clear statement of a real strategic change, and the counter-UAS example shows it produces hardware rather than presentations. The financial discipline claimed is that these investments are incremental to the guided forecast rather than embedded in it, so any resulting orders are upside. That is the right way to disclose it. It also means the spending is certain and the revenue is not, which is the standard trade for optionality and is affordable at current cash generation.

Whether commercial-style contracting survives a change of administration

The most substantive strategic challenge of the call invoked the C-130J precedent, where the company self-funded development, earned commercial-like margins and then lost the commercial designation by Pentagon reversal. The answer conceded the risk cannot be eliminated and argued that enforceable long-term agreements are a materially different instrument from an administrative designation.

Q: "So how confident are you that the current administration's push towards a commercial acquisition system will be durable rather than reversed by a future administration?"
— Scott Mikus, Melius Research

A: "So those agreements will have to stand the test of time. As circumstances budgets and political leadership is going to change over time."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: The candour is the valuable part. Management did not claim the agreements are immune, only that they are enforceable in a way the C-130J designation was not, and stated that the company will not again take an investment position without contractual protection. We regard the political durability of this contracting model as the principal long-term risk to the munitions thesis, ranking ahead of physical execution, and it is essentially unhedgeable for a shareholder.

The disconnect between record backlog and the share price

An unusually direct question asked management to reflect on why the stock had been weak against demand signals this strong. The response attributed it to the newness of the munitions contracting model and predicted the gap closes as framework agreements convert into definitized contracts and near-term revenue visibility improves.

Q: "So the demand indications, the demand signals, say, revenue is accelerating. -- needless to say the stock price over the last few months suggests a lot of concern about that. I was hoping that you could just reflect on that and maybe give people confidence in the revenue growth outlook from here"
— John Godyn, Citi

A: "And in terms of the stock price, and I do think given the newness of what we're seeing here with the way to acquire these munitions I mean there's some learning that's going to happen, I think, as investors continue to understand it better."
— Evan Scott, Chief Financial Officer

Assessment: Management diagnosed this correctly, and the day's 10.5% move is the proof. The market was discounting framework agreements and paying for definitized contracts, which is disciplined rather than confused. Our own coverage did the same thing, and this quarter is where the evidence caught up. The remaining discount should close as PAC-3 definitizes in the second half.

Risk across the portfolio, and the classified programs

A broad question sought an update on the two classified programs and on risk across the business generally. The answer confirmed both classified baselines have held, and reframed the portfolio risk question around scaling breadth: four Sikorsky platforms, F-16 and C-130, and ten munitions programs all delivering more units in 2026 than 2025.

Q: "Maybe an update to the extent you can provide 1 on those programs? And if there are any milestones or meaningful things that we should be looking for on those programs, in particular, over the next couple of quarters?"
— Gautam Khanna, TD Cowen

A: "I think the thing to look for is resilience, right? Two things, can we scale and can we be resilient."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: Four clean quarters on the Aeronautics classified program and six on the MFC program clears the bar we set at initiation. The reframing toward scale-and-resilience is fair and the F-16 recovery within a single quarter supports it. What the answer sidesteps is that the resilience test has now been run five consecutive quarters at Sikorsky and has not yet been passed there.

Capex efficiency and what it means for 2027 investment

The most financially consequential question asked what drove the capex reduction and how to think about the level of investment beyond 2026. The answer separated timing from genuine efficiency, credited the customer partnership for the latter, and disclosed the total program size for the first time.

Q: "How do we think about just the CapEx efficiencies that you're seeing and how we think about 27 and how the customer funding looks as we think about level of investments this year and going forward?"
— Sheila Kahyaoglu, Jefferies

A: "So you're going to see us continue to be in a growth and investment mode over the next few years."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: The disclosure that the total munitions capital commitment is $8B to $9B and unchanged is what we had been asking for since January, and getting it alongside a lower near-term spend is the best possible combination. It bounds the commitment, confirms the capacity target is intact, and demonstrates the partnership is producing efficiency rather than just cash timing. This exchange did more to resolve our capital-intensity concern than anything else in the quarter.

Long-term margin trajectory at Missiles and Fire Control

Following the best MFC margin quarter in some time, a question asked whether the improvement can continue into 2027 given management's prior warnings about early-phase dilution. The answer set a durable range and repeated the dilution ceiling while raising the eventual destination above historical levels.

Q: "Is there scope for that to continue to improve? And should we think about improving into 2027?"
— Matthew Akers, BNP Paribas

A: "So -- we would still think about near-term dilution in the 20 to 30 basis points over the next few years with a goal to get to higher than historic margins on. So for next year, I think, generally speaking, this year is a good reflection within 20 to 30 basis points."
— Evan Scott, Chief Financial Officer

Assessment: Management has now repeated the same 20 to 30 basis point ceiling in three consecutive quarters and delivered better than it twice. Setting 2027 expectations at "this year within 20 to 30 basis points" puts MFC margin in a 13.6% to 14.2% band, which is a specific and checkable commitment on the segment carrying most of the company's growth. Combined with the repricing mechanism that lets efficiency gains be retained, the path above historical margins is credible rather than aspirational.

The 45-day counter-UAS development and its revenue potential

A question on the counter-UAS demonstrator that went from concept to live fire in 45 days asked management to size the opportunity from this faster development approach. The answer described the integration in detail, including a radar sourced from a venture portfolio company and a mass-produced missile repurposed for a new mission, and management confirmed it had directed production of a thousand units without a contract in hand.

Q: "45 days is pretty impressive for what you delivered -- so can you size the revenue opportunity that you can tackle on with this new development approach and how you see your potential market share for incremental programs evolve with this with this faster turnaround."
— Kristine Liwag, Morgan Stanley

A: "So that's the mentality we have now. And then there's so many young people. We have the 60,000-plus engineers and scientists."
— James Taiclet, Chairman, President and Chief Executive Officer

Assessment: The question asked for a number and did not get one, which is the correct disclosure posture for uncontracted programs but leaves the opportunity unpriceable. The interesting disclosure is the mechanism: the value was created by integrating a venture-portfolio radar, an existing battle manager and a missile already produced at scale, not by inventing anything. That is a repeatable capability rather than a one-off, and it is the clearest demonstration yet that the venture fund and the corporate R&D reallocation are connected to product. We assign no value pending an order.

What They're NOT Saying

1. Anything at all about the buyback. Zero shares repurchased in Q2, zero in the first half, against $1,250M a year ago. It was not mentioned in the prepared remarks and no analyst asked. With free cash flow guided to $7,100M, dividends running near $3.2B and capex now $450M lower, the capacity exists. Two quarters of silence on a framework that returned roughly 100% of free cash flow for years is a conspicuous omission.
2. Why F-35 deliveries are running so far behind. Nineteen aircraft in the quarter against fifty, and fifty-one in the half against ninety-seven, leaves 105 required in the second half to hold the 156-aircraft rate. The release does not explain the shortfall and no analyst pressed it. Aeronautics revenue rose regardless, which makes it a working-capital and recognition question rather than a demand one, but it is unaddressed.
3. What is structurally wrong at Sikorsky. Heavy Lift and Seahawk adjustments this quarter make five consecutive quarters of negative rotorcraft news across at least six distinct programs. Each has been explained individually; none has been explained collectively, and no remediation plan has been disclosed for a business inside a segment carrying $48,454M of backlog.
4. Where capital expenditure settles after 2026. The total munitions commitment is now sized at $8B to $9B, which is real progress, but the annual profile is not. If roughly $2.2B lands in 2026, the remaining $6B to $7B has no disclosed schedule, and management said only that investment mode continues "over the next few years."
5. The PAC-3 multi-year timing beyond "second half." The largest remaining definitization is guided to the second half of 2026 without a month or a value. Since the THAAD conversion added $41B to backlog in a single quarter, the PAC-3 equivalent is material to both backlog and to the 2027 revenue bridge.
6. Any 2027 framework. Four quarters into a capital program management describes as multi-year, there is still no multi-year revenue, margin or cash guidance. Given that the entire case for the capex rests on returns arriving in 2028 and beyond, the absence of an out-year framework leaves investors underwriting the spend without the payoff quantified.
7. What happens to the ULA stake. The joint venture has now been a negative earnings swing factor in three of four quarters and has forced down the Space profit guide pending a launch anomaly investigation. Management has not addressed whether the holding remains strategic.

Market Reaction

• Pre-print setup: LMT closed at $514.36 on July 22, 24.0% below the $676.70 52-week closing high and the second-lowest pre-print close in our coverage, behind only the $505.90 that preceded our initiation. The stock was up only 6.3% year to date against the S&P 500's 9.5%, trailing the index by roughly three points, though still up 22.6% over the trailing twelve months and 2.1% over the trailing thirty days.
• Reaction session: The stock gapped up 6.0% to open at $545.00, ran to a $576.00 intraday high, and closed at $568.59, up 10.5% or $54.23.
• Volume: 3.3M shares against a 1.2M thirty-day average, 2.7x normal.
• Benchmark: The S&P 500 fell 1.2% on the session, so the move was entirely stock-specific and then some.

A 10.5% single-day move in a $130B defense prime is not a reaction to a $0.72 earnings beat. It is a repricing of the forward cash and capital story, and the components are identifiable: free cash flow guided up $450M, capex guided down $450M, and $43,989M of backlog added on a contract that converts a framework into a seven-year commitment. Each of those addressed a specific reason the stock had been discounted, and they arrived together.

The setup explains the magnitude. LMT entered the print trailing the index year to date and 24% off its high, with the market having spent two quarters declining to pay for framework agreements. When the framework became a definitized $35B contract and the capital cost of servicing it came down rather than up, the discount had no remaining justification. The stock closed near its highs and gave back only $7.41 from the intraday peak, which for a move this size indicates conviction rather than a squeeze.

Street Perspective

Debate: Does the raised guide represent real earnings growth or continued normalisation?

Bull view: The bull case being made on the Street is that this is the quarter the story stopped being about charge recovery. Sales grew 7% excluding prior-year adjustments, segment margin improved 66bps sequentially, free cash flow swung $3.2B, and the guide rose on sales, EPS and cash while capex fell. Every line moved the right way for operating reasons.

Bear view: The bear camp contends that the arithmetic we have applied all year still holds: against a clean 2025 base, the raised guide is 2.9% profit growth, 6.3% EPS growth, and margin 49bps lower. The $2,000M revenue raise carried only $50M of profit, a 2.5% incremental margin, and cash from operations guidance did not move at all. The entire free cash flow raise is a capex reduction.

Our take: Both are correct and the bulls have the better claim on what changed. The clean-basis growth rate is still modest and we continue to report it, but the composition of this quarter is different in kind from the prior three: margin improved sequentially, cash improved absolutely, and the improvement came from operations rather than from the share count or a favourable comparison. The 2.5% incremental margin on the revenue raise is expected behaviour for early-stage ramp revenue, not a warning, and it means the profit arrives in 2028 and later. That is a reason to own the stock for three years, not three months.

Debate: Is the munitions capital program a value creator or a cash sink?

Bull view: The bull case is that this quarter resolved the question decisively. The total commitment is $8B to $9B and unchanged; the 2026 tranche came in $450M below plan; the framework agreements are cash-neutral with customer advance payments; allied co-production is absorbing capacity expansion the company would otherwise fund; and the repricing mechanism lets Lockheed retain efficiency gains rather than surrendering them at the next cost review. Backlog of $87,882M at MFC underwrites all of it.

Bear view: The bear camp contends that $6B to $7B of the commitment remains unscheduled, that the physical ramp to 2,000 PAC-3 units per year takes three to four years on management's own account, and that the returns depend on a commercial contracting model whose durability across administrations management itself declined to guarantee. Meanwhile the buyback has been zero for two quarters and there is still no out-year return framework.

Our take: The bulls have this, and it is the basis for our upgrade. We opened this bear point in January precisely because the program was unsized and the commitment to hold capital intensity had just been broken. It is now sized, coming in under plan, partly customer-funded, and attached to a definitized seven-year contract with a mechanism that lets the investor keep the productivity gains. The unscheduled portion and the political durability question are real, but they are ordinary risks rather than the structural objection we raised.

Debate: Is 18.8x the right multiple for this business now?

Bull view: At $568.59 the stock trades at 18.8x the raised 2026 midpoint with a 5.4% free cash flow yield and a 2.4% dividend, on backlog covering 2.85 years of sales, with both classified programs stable for four and six quarters respectively and the segment carrying most of the growth expanding margin against a commitment to dilute. It is still 16% below its high.

Bear view: The bear camp contends the multiple should reflect a business whose clean earnings grow at mid-single digits, whose largest segment by revenue is guided to flat margin, whose rotorcraft franchise has disappointed five quarters running, and which has stopped returning capital to shareholders in the form the market had come to rely on.

Our take: We restore our multiple band to 20x to 22x, back to where we carried it before the Q1 miss, giving a fair value range of $606 to $667 with a midpoint of $637 and roughly 12% upside plus a 2.4% dividend. The restoration is justified by the resolution of the capital-intensity question, the definitized THAAD contract, the cash reversal, and the retained-efficiency mechanism, which collectively lower both the variance and the long-run margin ceiling of this business. The Sikorsky problem and the absent buyback are why we stop at 22x rather than going higher.

Model Update Needed

Valuation: We raise our fair value range to $606 to $667 from $536 to $596, on a restored 20x to 22x multiple applied to a raised $30.30 FY2026 EPS estimate. The midpoint of $637 implies roughly 12% upside from the $568.59 close, or roughly 14% including the dividend. Both the multiple and the estimate move this quarter, which is unusual and reflects that the quarter changed both what the company will earn and how confident we are in it.

Thesis Scorecard Post-Earnings

Overall: The thesis is materially stronger. Three of the four bear points we have carried since initiation have now been answered with evidence rather than assurance, and the one that remains is confined to a single business unit inside a single segment. The bull pillars are all confirmed, with the munitions pillar converted from a demand forecast into a definitized seven-year contract carrying a mechanism that lets the company keep what it earns from investing. Nine months ago we initiated on the view that Lockheed had the best order book in the sector and no demonstrated ability to convert it into growing earnings or uncommitted cash. It has now demonstrated both.

Action: Upgrading to Outperform from Hold, with a fair value range of $606 to $667. In April we set three conditions: positive free cash flow confirming the ERP reversal, no new program adjustments, and segment margin above 11%. The first was met emphatically, the second only at Aeronautics and not at Sikorsky, and the third was missed by 22bps as reported and cleared at 11.35% excluding the RMS adjustments. Two and a half of three would ordinarily leave us waiting another quarter. What decides it is the capex line, which was not on our list and matters more than any item that was: a company delivering an unchanged capacity target for $450M less capital, with the customer funding the working capital and a contract structure that lets it retain the productivity gains, is a different investment than the one we rated Hold. April also set an Underperform trigger on further F-16, C-130 or Sikorsky adjustments, and Sikorsky delivered $115M of them. We are not acting on it, and the reason should be explicit: that trigger was written when the adjustments were spread across four programs in two segments alongside a deteriorating cash line. This quarter they were confined to one business unit while free cash flow, backlog, capital intensity and guidance all moved decisively the other way. We carry Sikorsky forward as the open bear point rather than as a downgrade. We would return to Hold above $660, or on evidence that the PAC-3 multi-year slips beyond 2026. We would move to Underperform on a new reach-forward loss at either classified program, or on MFC margin falling more than 30bps below the 13.8% base.